Cited by 1,360Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsGenetic and Kidney Cyst Diseases

The DOI matches its Crossref record; 179 of the 181 references it cites were found in a registry or an index.

Polycystic ovary syndrome

Norman, Robert J, Dewailly, Didier, Legro, Richard S, Hickey, Theresa E·2007·The Lancet

DOI 10.1016/s0140-6736(07)61345-2

Open this paper in CoChat — free account

Abstract

Polycystic ovary syndrome is a heterogeneous endocrine disorder that affects about one in 15 women worldwide. The major endocrine disruption is excessive androgen secretion or activity, and a large proportion of women also have abnormal insulin activity. Many body systems are affected in polycystic ovary syndrome, resulting in several health complications, including menstrual dysfunction, infertility, hirsutism, acne, obesity, and metabolic syndrome. Women with this disorder have an established increased risk of developing type 2 diabetes and a still debated increased risk of cardiovascular disease. The diagnostic traits of polycystic ovary syndrome are hyperandrogenism, chronic anovulation, and polycystic ovaries, after exclusion of other conditions that cause these same features. A conclusive definition of the disorder and the importance of the three diagnostic criteria relative to each other remain controversial. The cause of polycystic ovary syndrome is unknown, but studies suggest a strong genetic component that is affected by gestational environment, lifestyle factors, or both.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(07)61345-2

Cites

179 of 179 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,776
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yıldız, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,715
Clinical assessment of body hair growth in women.
Ferriman, D., & Gallwey, J. D. (1961) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,556
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Self-citation
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121

Show all 181 references

Research works printed but not linked: 5

Azziz, 2006, Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess Society guideline, J Clin Endocrinol Metab, 91, 4237, 10.1210/jc.2006-0178 · DOI · Paper page
Legro, 1999, Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women, J Clin Endocrinol Metab, 84, 165
Legro, 2006, Pregnancy in polycystic ovary syndrome (PPCOS) baseline characteristics: effect of race and ethnicity on the PCOS phenotype, J Soc Gynecol Investig, 13, 268a
van Vloten, 2002, The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea, Cutis, 69, 2
Hughes, 2000, Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome, Cochrane Database Syst Rev, 2

Sorted by citations

Items 601–700 of 1,000

One Environmental Health: an emerging perspective in toxicology
Pérez, A. A., & Wise, J. P. (2018) · F1000Research · doi:10.12688/f1000research.14233.1 · Cited by 22
Maternal High-Fat Diet Consumption and Chronic Hyperandrogenemia Are Associated With Placental Dysfunction in Female Rhesus Macaques
Kuo, K., Roberts, V. H. J., Gaffney, J. E., Takahashi, D. L., Morgan, T. K., Lo, J. O.-T., Stouffer, R. L., & Frias, A. E. (2019) · Endocrinology · doi:10.1210/en.2019-00149 · Cited by 22
Cortisol-Metabolizing Enzymes in Polycystic Ovary Syndrome
Blumenfeld, Z., Kaidar, G., Zuckerman‐Levin, N., Dumin, E., Knopf, C. F., & Hochberg, Z. (2016) · Clinical Medicine Insights Reproductive Health · doi:10.4137/cmrh.s35567 · Cited by 22
Prediabetes and diabetes in a cohort of Qatari women screened for polycystic ovary syndrome
Dargham, S. R., Elshewehy, A. M. M., Dakroury, Y., Kilpatrick, E. S., & Atkin, S. L. (2018) · Scientific Reports · doi:10.1038/s41598-018-21987-6 · Cited by 21
Association between empirically derived dietary patterns and polycystic ovary syndrome: A case-control study
Panjeshahin, A., Salehi-Abargouei, A., Anari, A. G., Mohammadi, M., & Hosseinzadeh, M. (2020) · Nutrition · doi:10.1016/j.nut.2020.110987 · Cited by 21
Exploring the association of ESR1 and ESR2 gene SNPs with polycystic ovary syndrome in human females: a comprehensive association study
Muccee, F., Ashraf, N. M., Razak, S., Afsar, T., Hussain, N., Husain, F. M., & Shafique, H. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-023-01335-7 · Cited by 21
Polymorphisms of transcription factor-7-like 2 (TCF7L2) gene in Tunisian women with polycystic ovary syndrome (PCOS)
Salem, A. B., Ajina, M., Suissi, M., Daher, H. S., Almawi, W. Y., & Mahjoub, T. (2013) · Gene · doi:10.1016/j.gene.2013.09.104 · Cited by 21
Acupuncture for treating polycystic ovary syndrome: guidance for future randomized controlled trials
Wu, Y. T., Robinson, N., Hardiman, P. J., Taw, M. B., Zhou, J., Wang, F., & Qu, F. (2016) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1500301 · Cited by 21
Impact of metformin on C-reactive protein levels in women with polycystic ovary syndrome: a meta-analysis
Chen, Y., Li, M., Deng, H., Wang, S., Chen, L., Li, N., Xu, D., & Wang, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.16019 · Cited by 21
Gonadotrophins versus clomiphene citrate with or without IUI in women with normogonadotropic anovulation and clomiphene failure: a cost-effectiveness analysis
Bordewijk, E. M., Weiss, N. S., Nahuis, M. J., Bayram, N., van Hooff, M. H. A., Boks, D. E. S., Perquin, D. A. M., Janssen, C. A. H., van Golde, R. J. T., Lambalk, C. B., et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey359 · Cited by 21
Role of metformin in functional endometrial hyperplasia and polycystic ovary syndrome involves the regulation of MEG3/miR‑223/GLUT4 and SNHG20/miR‑4486/GLUT4 signaling
Liu, J., Zhao, Y., Chen, L., Li, R., Ning, Y., & Zhu, X. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12734 · Cited by 21
Evidence for TET-mediated DNA demethylation as an epigenetic alteration in cumulus granulosa cells of women with polycystic ovary syndrome
Sagvekar, P., Shinde, G., Mangoli, V. S., Desai, S. K., & Mukherjee, S. (2022) · Molecular Human Reproduction · doi:10.1093/molehr/gaac019 · Cited by 21
Review of the effects of polycystic ovary syndrome on Cognition: Looking beyond the androgen hypothesis
Perović, M., Wugalter, K. A., & Einstein, G. (2022) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2022.101038 · Cited by 21
Can high serum anti-Müllerian hormone levels predict the phenotypes of polycystic ovary syndrome (PCOS) and metabolic disturbances in PCOS patients?
Hwang, Y. I., Sung, N., Koo, H. S., Cha, S. H., Park, C. W., Kim, J. Y., Yang, K. M., Song, I. O., Koong, M. K., Kang, I. S., et al. (2013) · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine · doi:10.5653/cerm.2013.40.3.135 · Cited by 22
The Relationship between Adiposity and Insulin Sensitivity in African Women Living with the Polycystic Ovarian Syndrome: A Clamp Study
Doh, E., Mbanya, A., Ngowa, J. D. K., Dohbit, S., Tchana-Sinou, M., Foumane, P., Donfack, O. T., Doh, A. S., Mbanya, J. C., & Sobngwi, E. (2016) · International Journal of Endocrinology · doi:10.1155/2016/9201701 · Cited by 21
Demographic analysis of a low resource, socioculturally diverse urban community presenting for infertility care in a United States public hospital
Ho, J. R., Hoffman, J. R., Aghajanova, L., Smith, J. F., Cardenas, M., & Herndon, C. N. (2017) · Contraception and Reproductive Medicine · doi:10.1186/s40834-017-0044-7 · Cited by 23
Predictive factors for live birth after in vitro maturation of oocytes in women with polycystic ovary syndrome
Tannus, S., Hatırnaz, Ş., Tan, J., Ata, B., Tan, S. L., Hatırnaz, E. S., Pektas, M. K., & Dahan, M. H. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4561-z · Cited by 21
Prediction of in vitro fertilization outcome at different antral follicle count thresholds combined with female age, female cause of infertility, and ovarian response in a prospective cohort of 8269 women
Liao, S., Xiong, J., Tu, H., Hu, C., Pan, W., Geng, Y., Pan, W. D., Lu, T., & Jin, L. (2019) · Medicine · doi:10.1097/md.0000000000017470 · Cited by 21
Polycystic Ovary Syndrome: Special Diagnostic and Therapeutic Considerations for Children
Kamangar, F., Okhovat, J., Schmidt, T. H., Beshay, A. P., Pasch, L. A., Cedars, M. I., Huddleston, H. G., & Shinkai, K. (2015) · Pediatric Dermatology · doi:10.1111/pde.12566 · Cited by 21
The relationship between LH and thyroid volume in patients with PCOS
Çakır, E., Şahi̇n, M., Topaloğlu, O., Çolak, N., Karbek, B., Güngüneş, A., Arslan, M. S., Ünsal, İ. Ö., Tutal, E., Uçan, B., et al. (2012) · Journal of Ovarian Research · doi:10.1186/1757-2215-5-43 · Cited by 21
Antimüllerian hormone, antral follicle count and ovarian volume predict menstrual cycle length in healthy women
Zhu, R., Lee, B. H., Huang, Z., Indran, I. R., Li, J., Shen, L., Kramer, M. S., & Yong, E. (2015) · Clinical Endocrinology · doi:10.1111/cen.12984 · Cited by 21
Urogenital System
Cline, J. M., Brignolo, L. L., & Ford, E. W. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381366-4.00010-9 · Cited by 21
Characteristics of heart rate variability in women with polycystic ovary syndrome
Ji, H. R., Woo, H. L., Park, Y.-J., Hwang, D. S., Lee, J., Lee, C. H., Jang, J. B., & Park, K. S. (2018) · Medicine · doi:10.1097/md.0000000000012510 · Cited by 20
Long non-coding RNATUG1and its molecular mechanisms in polycystic ovary syndrome
Li, Y., Zhang, J., Liu, Y., Zhou, X., Chen, X., Zhe, J., Zhang, Q., Zhang, X., Chen, Y.-X., Wang, Z., et al. (2020) · RNA Biology · doi:10.1080/15476286.2020.1783850 · Cited by 21
Associations of Serum Magnesium With Insulin Resistance and Testosterone in Women With Polycystic Ovary Syndrome
Luo, X., Cai, W.-Y., Ma, H., Cong, J., Chang, H., Gao, J., Shen, W., Wang, Y., Yang, X., & Wu, X. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.683040 · Cited by 20
Obesity modulates cell-cell interactions during ovarian folliculogenesis
Long, X., Yang, Q., Qian, J., Yao, H., Yan, R., Cheng, X., Zhang, Q., Gu, C., Gao, F., Wang, H., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103627 · Cited by 24
Phytotherapy of polycystic ovary syndrome: A review
Azin, F., & Khazali, H. (2022) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v20i1.10404 · Cited by 21
LINC00173 regulates polycystic ovarian syndrome progression by promoting apoptosis and repressing proliferation in ovarian granulosa cells via the microRNA-124-3p (miR-124-3p)/jagged canonical Notch ligand 1 (JAG1) pathway
Chen, L., & Kong, C. (2022) · Bioengineered · doi:10.1080/21655979.2022.2053797 · Cited by 20
Antioxidative Effects of Standardized Aronia melanocarpa Extract on Reproductive and Metabolic Disturbances in a Rat Model of Polycystic Ovary Syndrome
Rudic, J., Jakovljevic, V. L., Jovic, N., Muric, M. D., Sretenovic, J. Z., Mitrović, S., Bolevich, S., Bolevich, S. S., Mitrović, M., Raičević, S., et al. (2022) · Antioxidants · doi:10.3390/antiox11061099 · Cited by 20
RETRACTED ARTICLE: Long non-coding RNA-X-inactive Specific Transcript inhibits cell viability, and induces apoptosis through the microRNA-30c-5p/Bcl2-like protein 11 signaling axis in human granulosa-like tumor cells
Guo, Y., Peng, X., Cheng, R., Chen, H., & Luo, X. (2022) · Bioengineered · doi:10.1080/21655979.2022.2080366 · Cited by 20
Retracted
ANGPTL4 inhibits granulosa cell proliferation in polycystic ovary syndrome by EGFR / JAK1 / STAT3 ‐mediated induction of p21
Jiang, Q., Miao, R., Wang, Y., Wang, W., Zhao, D., Niu, Y., Ding, Q., Li, Y., Leung, P. C. K., Wei, D., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202201246rr · Cited by 20
Exploring the potential of machine learning in gynecological care: a review
Khan, I., & Khare, B. K. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07479-1 · Cited by 20
Therapeutic Effect of Korean Red Ginseng Extract on Infertility Caused by Polycystic Ovaries
Jung, J.-H., Park, H., Kim, T., Jeong, M.-J., Lim, S., Nah, S.-Y., Cho, I., Park, S., Kang, S.-S., Moon, C., et al. (2011) · Journal of Ginseng Research · doi:10.5142/jgr.2011.35.2.250 · Cited by 20
Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome
Koiou, E., Τζιόμαλος, Κ., Katsikis, I., Delkos, D., Tsourdi, E. A., & Panidis, D. (2013) · HORMONES · doi:10.14310/horm.2002.1444 · Cited by 20
Hyperandrogénie féminine
Peigné, M., Villers-Capelle, A., Robin, G., & Dewailly, D. (2013) · La Presse Médicale · doi:10.1016/j.lpm.2013.07.016 · Cited by 20
Self-citation
Predictors of Depression in Iranian Women with Polycystic Ovarian Syndrome
Mirghafourvand‬‬‬‬‬‬‬‬‬‬‬‬‬‬, M., Mohammad‐Alizadeh‐Charandabi, S., Behroozi-Lak, T., & Aliasghari, F. (2017) · Community Mental Health Journal · doi:10.1007/s10597-017-0188-6 · Cited by 20
Prenatal exposure to testosterone induces cardiac hypertrophy in adult female rats through enhanced Pkcδ expression in cardiac myocytes
Hou, M., Gu, H., Wang, H. H., Liu, X., Zhou, C., Yang, Q., Jiang, Z.-R., Lin, J., Wu, Y., Wu, Y., et al. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.01.008 · Cited by 20
The value of anti-Mullerian hormone in the management of polycystic ovary syndrome in adolescents
Asanidze, E., Kristesashvili, J., Pkhaladze, L., & Khomasuridze, A. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1616689 · Cited by 20
Analysis of VEGF gene polymorphisms and serum VEGF protein levels contribution in polycystic ovary syndrome of patients
Bao, L., Syed, R., & Aloahd, M. S. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-05015-y · Cited by 20
The effect of clomiphene citrate on oxidative stress parameters in polycystic ovarian syndrome
Peker, N., Turan, G., Ege, S., Bademkıran, M. H., Karaçor, T., & Erel, Ö. (2020) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2020.1719052 · Cited by 20
Serum and follicular fluid chemerin and chemerin mRNA expression in women with polycystic ovary syndrome: Systematic review and meta‐analysis
Mansoori, A., Amoochi-Foroushani, G., Zilaee, M., Hosseini, S. A., & Azhdari, M. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.307 · Cited by 20
Serum galectin-3 levels in women with PCOS
Yılmaz, H., Celik, H. T., Özdemir, Ö., Kalkan, D., Namuslu, M., Abuşoğlu, S., Atalay, C., & Yiğitoğlu, R. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-013-0032-y · Cited by 20
Effects of Adiponectin Including Reduction of Androstenedione Secretion and Ovarian Oxidative Stress Parameters In Vivo
Comim, F. V., Gutierrez, K., Bridi, A., Bochi, G. V., Chemeris, R., Rigo, M. L., Dau, A. M. P., Cezar, A. S., Moresco, R. N., & Gonçalves, P. B. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154453 · Cited by 22
Gly972Arg of IRS-1 and Lys121Gln of PC-1 polymorphisms act in opposite way in polycystic ovary syndrome
Pappalardo, M. A., Vita, R., Bari, F. D., Donne, M. L., Trimarchi, F., & Benvenga, S. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0569-7 · Cited by 20
Prevalence of Polycystic Ovary Syndrome in Nigerian Women with Infertility: A Prospective Study of the Three Assessment Criteria
Akpata, C. B., Uadia, P. O., & Okonofua, F. E. (2018) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2018.812112 · Cited by 19
Ovulation rates in a stair-step protocol with Letrozole vs clomiphene citrate in patients with polycystic ovarian syndrome
Thomas, S. A., Woo, I., Ho, J. R., Jones, T., Paulson, R. J., Chung, K., & Bendikson, K. A. (2019) · Contraception and Reproductive Medicine · doi:10.1186/s40834-019-0102-4 · Cited by 20
Skeletal Muscle Immunometabolism in Women With Polycystic Ovary Syndrome: A Meta-Analysis
Manti, M., Stener‐Victorin, E., & Benrick, A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.573505 · Cited by 18
Effects of exogenous adiponectin supplementation in early pregnant PCOS mice on the metabolic syndrome of adult female offspring
Zuo, M., Liao, G., Zhang, W., Xu, D., Lü, J., Tang, M., Yan, Y., Hong, C., & Wang, Y. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-020-00755-z · Cited by 19
The Effect of Hydroalcoholic Calendula Officinalis Extract on Androgen‐Induced Polycystic Ovary Syndrome Model in Female Rat
Gharanjik, F., Shojaeifard, M. B., Karbalaei, N., & Nemati, M. (2022) · BioMed Research International · doi:10.1155/2022/7402598 · Cited by 21
ITL-CNN: Integrated Transfer Learning-Based Convolution Neural Network for Ultrasound PCOS Image Classification
Gopalakrishnan, C., & Iyapparaja, M. (2022) · International Journal of Pattern Recognition and Artificial Intelligence · doi:10.1142/s021800142240002x · Cited by 19
Hormonal and metabolic effects of polyunsaturated fatty acid (omega-3) on polycystic ovary syndrome induced rats under diet.
Ouladsahebmadarek, E., Khaki, A., Khanahmadi, S., Ashtiani, H. A., Paknejad, P., & Ayubi, M. R. (2014) · Europe PMC (PubMed Central) · Cited by 19
Role of A-kinase anchoring protein 95 in the regulation of cytochrome P450 family 19 subfamily A member 1 (CYP19A1) in human ovarian granulosa cells
Gu, Y., Xu, W., Zhuang, B., & Fu, W. (2018) · Reproduction Fertility and Development · doi:10.1071/rd17313 · Cited by 19
Circulating Endothelial Microparticles Reduce in Concentration Following an Exercise Programme in Women With Polycystic Ovary Syndrome
Kirk, R. J., Madden, L. A., Peart, D. J., Aye, M. M., Atkin, S. L., & Vince, R. V. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00200 · Cited by 19
MicroRNA‑30d‑5p promotes ovarian granulosa cell apoptosis by targeting Smad2
Yu, M., & Liu, J. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8184 · Cited by 19
Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer
Xiong, Y., Bian, C., Lin, X., Wang, X., Xu, K., & Zhao, X. (2020) · Bioscience Reports · doi:10.1042/bsr20200995 · Cited by 20
LncRNA GAS5 is upregulated in polycystic ovary syndrome and regulates cell apoptosis and the expression of IL-6
Wang, C., Yue, S., Jiang, Y., Mao, Y., Zhao, Z., Liu, X., Zhang, X., Pei, D., & Li, Y. (2020) · Journal of Ovarian Research · doi:10.1186/s13048-020-00748-y · Cited by 19
Urinary Metabolites Reveal Hyperinsulinemia and Insulin Resistance in Polycystic Ovarian Syndrome (PCOS)
Fulghesu, A. M., Piras, C., Dessì, A., Succu, C., Atzori, L., Pintus, R., Gentile, C., Angioni, S. L., & Fanos, V. (2021) · Metabolites · doi:10.3390/metabo11070437 · Cited by 20
A randomized sham-controlled trial of manual acupuncture for infertile women with polycystic ovary syndrome
Pan, W., Li, F.-X., Wang, Q., Yin, X., Huang, Z., Yan, Y.-M., Zhao, L., & Shen, X. (2021) · Integrative Medicine Research · doi:10.1016/j.imr.2021.100830 · Cited by 19
Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: A randomized controlled trial
Leelaphiwat, S., Jongwutiwes, T., Lertvikool, S., Tabcharoen, C., Sukprasert, M., Rattanasiri, S., & Weerakiet, S. (2014) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12543 · Cited by 19
Promising clinical practices of metformin in women with PCOS and early-stage endometrial cancer
Shao, R., Li, X., & Billig, H. (2014) · BBA Clinical · doi:10.1016/j.bbacli.2014.07.001 · Cited by 19
Association of chromosome 9p21 SNPs with cardiovascular phenotypes in morbid obesity using electronic health record data
Wood, G. C., Still, C. D., Chu, X., Susek, M., Erdman, R., Hartman, C., Yeager, S. F., Blosky, M. A., Krum, W., Carey, D. J., et al. (2008) · Genomic Medicine · doi:10.1007/s11568-008-9023-z · Cited by 19
Heart rate variability and heart rate turbulence in patients with polycystic ovary syndrome
Özkeçeci, G., Ünlü, B. S., Dursun, H., Akçi, Ö., Köken, G., Onrat, E., & Avşar, A. (2015) · The Anatolian Journal of Cardiology · doi:10.5152/anatoljcardiol.2015.6307 · Cited by 19
How does acupuncture affect insulin sensitivity in women with polycystic ovary syndrome and insulin resistance? Study protocol of a prospective pilot study
Zheng, Y., Stener‐Victorin, E., Ng, E. H. Y., Li, J., Wu, X., & Ma, H. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007757 · Cited by 19
Heterogenous origins of hyperandrogenism in the polycystic ovary syndrome in relation to body mass index and insulin resistance
Patlolla, S., Vaikkakara, S., Sachan, A., Venkatanarasu, A., Bachimanchi, B., Bitla, A. R. R., Settipalli, S., Pathiputturu, S., Sugali, R. N., & Chiri, S. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1393062 · Cited by 19
Towards Hormone Health: An Autoethnography of Long-Term Holistic Tracking to Manage PCOS
Kang, D., Li, J., Leshed, G., Rzeszotarski, J. M., & Lu, X. (2025) · CHI Conference on Human Factors in Computing Systems · doi:10.1145/3706598.3713619 · Cited by 20
Sam68 mediates leptin signaling and action in human granulosa cells: possible role in leptin resistance in PCOS
Vilariño‐García, T., Pérez‐Pérez, A., Santamaría‐López, E., Prados, N., Sánchez, M. F., & Sánchez‐Margalet, V. (2020) · Endocrine Connections · doi:10.1530/ec-20-0062 · Cited by 18
Effect of electroacupuncture on the kisspeptin system in a pubertal rat model of polycystic ovary syndrome
Wang, Z., Li, Y., Dong, H., Dong, H., Cheng, L., Yi, P., & Huang, D. (2021) · Acupuncture in Medicine · doi:10.1177/0964528420971299 · Cited by 18
The Interlink Between Metabolic-Associated Fatty Liver Disease and Polycystic Ovary Syndrome
Vidal‐Cevallos, P., Mijangos-Trejo, A., Uribe, M., & Chávez-Tapia, N. C. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2023.01.005 · Cited by 18
Metformin derivatives – Researchers’ friends or foes?
Torunoglu, S. T., Zajda, A., Tampio, J., Markowicz-Piasecka, M., & Huttunen, K. M. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115743 · Cited by 22
Promising drug candidates for the treatment of polycystic ovary syndrome (PCOS) as alternatives to the classical medication metformin
Anbar, H. S., Vahora, N. Y., Shah, H. L., Azam, M. M., Islam, T., Hersi, F., Omar, H. A., Döhle, W., Potter, B. V. L., & El-Gamal, M. I. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176119 · Cited by 17
Gut Microbiome Composition in Polycystic Ovary Syndrome Adult Women: A Systematic Review and Meta-analysis of Observational Studies
Zhu, Q., & Zhang, N. (2024) · Reproductive Sciences · doi:10.1007/s43032-023-01440-4 · Cited by 18
Polycystic Ovary Syndrome: Aggressive or Protective Factor for the Retina? Evaluation of Macular Thickness and Retinal Nerve Fiber Layers Using High-Definition Optical Coherence Tomography
Júnior, J. E. D. S., Garcia, C. A. D. A., Soares, E. M. M., Maranhão, T. M. O., Lemos, T. M. A. M., & Azevedo, G. D. (2015) · Journal of Ophthalmology · doi:10.1155/2015/193078 · Cited by 18
Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome
Koiou, E., Τζιόμαλος, Κ., Dinas, K. D., Katsikis, I., Kandaraki, E., Tsourdi, E. A., Mavridis, S., & Panidis, D. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0023 · Cited by 18
Proteomic profiles in hyperandrogenic syndromes
Misiti, S., Stigliano, A., Borro, M., Gentile, G., Michienzi, S., Cerquetti, L., Bucci, B., Argese, N., Brunetti, E., Simmaco, M., et al. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346575 · Cited by 18
Processes Linking Father Absence to Educational Attainment Among African American Females
Gillette, M. T., & Gudmunson, C. G. (2013) · Journal of Research on Adolescence · doi:10.1111/jora.12066 · Cited by 18
Development of a novel risk prediction and risk stratification score for polycystic ovary syndrome
Deshmukh, H., Papageorgiou, M., Kilpatrick, E. S., Atkin, S. L., & Sathyapalan, T. (2018) · Clinical Endocrinology · doi:10.1111/cen.13879 · Cited by 18
Metformin in women with PCOS, CONS
Misso, M. L., & Teede, H. J. (2014) · Endocrine · doi:10.1007/s12020-014-0394-8 · Cited by 18
A 27-Year-Old Woman Diagnosed as Polycystic Ovary Syndrome Associated with Graves' Disease
Jung, J. H., Hahm, J. R., Jung, T. S., Kim, H. J., Kim, H. S., Kim, S., Kim, S. K., Lee, S. M., Kim, D. R., Choi, W. J., et al. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.5475 · Cited by 18
Retinal Nerve Fiber Layer Thickness in Women with Polycystic Ovary Syndrome
Demir, M., Güven, D., Koc, A., Özdemir, S., & Can, E. (2013) · Journal of Ophthalmology · doi:10.1155/2013/752186 · Cited by 18
Gestational Diabetes Mellitus and Metabolic Disorder Among the Different Phenotypes of Polycystic Ovary Syndrome
Ashrafi, M., Sheikhan, F., Arabipoor, A., Rouhana, N. A., Hosseini, R., & Zolfaghari, Z. (2017) · Oman Medical Journal · doi:10.5001/omj.2017.40 · Cited by 18
Lack of cyclical fluctuations of endometrial GLUT4 expression in women with polycystic ovary syndrome: Evidence for direct regulation of GLUT4 by steroid hormones
Cui, P., Li, X., Wang, X., Feng, Y., Lin, J.-F., Billig, H., & Shao, R. (2015) · BBA Clinical · doi:10.1016/j.bbacli.2015.08.004 · Cited by 18
The Phenotypes of Polycystic Ovary Syndrome Defined by the 1990 Diagnostic Criteria Are Associated with Higher Serum Vaspin Levels than the Phenotypes Introduced by the 2003 Criteria
Koiou, E., Dinas, K. D., Τζιόμαλος, Κ., Toulis, K. A., Kandaraki, E., Kalaitzakis, E., Katsikis, I., & Panidis, D. (2011) · Obesity Facts · doi:10.1159/000327935 · Cited by 18
Comparison of exenatide alone or combined with metformin versus metformin in the treatment of polycystic ovaries: a systematic review and meta-analysis
Hu, Y. P., Song, X., Hamiti, S., Ma, Y., Yusufu, M., Wang, X., Zhang, K., & Guo, Y. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01497-x · Cited by 17
Battey’s operation as a treatment for hysteria: a review of a series of cases in the nineteenth century
Komagamine, T., Kokubun, N., & Hirata, K. (2019) · History of Psychiatry · doi:10.1177/0957154x19877145 · Cited by 17
Relationship of PD‐1 (PDCD1) and PD‐L1 (CD274) Single Nucleotide Polymorphisms with Polycystic Ovary Syndrome
Han, R., Gong, X., Zhu, Y., Liu, X., Xia, Y., Huang, Y., Zhang, M., Zhang, Y., La, X., & Ding, J. (2021) · BioMed Research International · doi:10.1155/2021/9596358 · Cited by 17
MicroRNA-664a-3p inhibits the proliferation of ovarian granulosa cells in polycystic ovary syndrome and promotes apoptosis by targeting BCL2A1
He, M. Y., Mao, G., Xiang, Y., Li, P., Wu, Y., Zhao, D., & Tan, L. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-1614 · Cited by 17
Whole Genome Transcriptomic Analysis of Ovary Granulosa Cells Revealed an Anti-Apoptosis Regulatory Gene DLGAP5 in Polycystic Ovary Syndrome
Deng, Y. P., Hu, L., Song, Y., Cen, J., Zhang, Y., Sui, Y., Cui, D., Li, T. C., Xu, Y. L., Wang, C. C., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.781149 · Cited by 17
Genital Microbiota of Women From Six Ethnic Groups With and Without Human Papillomavirus Infection in Shangri-La, China
Liu, C., Xiao, W.-Y., Fang, J.-F., Dong, Y., Ye, K., He, M.-P., Wang, Y., Li, X., Zhao, Z., Yuan, T., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.935068 · Cited by 17
Putative Complementary Compounds to Counteract Insulin-Resistance in PCOS Patients
Petrillo, T., Semprini, E., Tomatis, V., Arnesano, M., Ambrosetti, F., Battipaglia, C., Sponzilli, A., Ricciardiello, F., Genazzani, A. R., & Genazzani, A. D. (2022) · Biomedicines · doi:10.3390/biomedicines10081924 · Cited by 18
Role of pyroglutamic acid in cumulus cells of women with polycystic ovary syndrome
Turathum, B., Gao, E.-M., Yang, F., Liu, Y., Yang, Z.-Y., Liu, C., Xue, Y., Wu, M.-H., Wang, L., Grataitong, K., et al. (2022) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-022-02647-1 · Cited by 17
Automatic Diagnosis of Polycystic Ovarian Syndrome Using Wrapper Methodology with Deep Learning Techniques
Abouhawwash, M. (2023) · Computer Systems Science and Engineering · doi:10.32604/csse.2023.037812 · Cited by 17
Metabolic Syndrome Rather Than Other Phenotypes in PCOS as a Predictive Indicator for Clinical Outcomes in IVF: Comprehensive Phenotypic Assessment across All PCOS Classifications
Si, M., Xu, W., Qi, X., Jiang, H., Zhao, Y., Li, R., Long, X., & Qiao, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12155073 · Cited by 16
Decreased miR-128-3p in serum exosomes from polycystic ovary syndrome induces ferroptosis in granulosa cells via the p38/JNK/SLC7A11 axis through targeting CSF1
Lv, Y., Han, S., Sun, F., Zhang, Y., Qu, X., Li, H., Gu, W., Xu, Q., Yao, S., Chen, X., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02331-0 · Cited by 17
Polycystic ovary syndrome: implications of metabolic dysfunction
de Ávila, M. A. P., Bruno, R. V., Barbosa, F. C., de Andrade, F. C., Silva, A. C. D. O. E., & Nardi, A. E. (2014) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/s0100-69912014000200006 · Cited by 39
Reproductive Endocrinology and Related Disorders
Isbell, T. S., Jungheim, E. S., & Gronowski, A. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6164-9.00056-1 · Cited by 17
Prediction of Responsiveness to Clomiphene Citrate in Infertile Women with PCOS.
Sachdeva, G., Gainder, S., Suri, V., Sachdeva, N. K., & Chopra, S. (2019) · Europe PMC (PubMed Central) · Cited by 17
Optimal control of dosage decisions in controlled ovarian hyperstimulation
He, M., Zhao, L., & Powell, W. B. (2009) · Annals of Operations Research · doi:10.1007/s10479-009-0563-y · Cited by 17
Anti-Müllerian hormone, testosterone and free androgen index following the dose-adjusted unilateral diathermy in women with polycystic ovary syndrome
Šunj, M., Canic, T., Jerončić, A., Karelović, D., Tandara, M., Petricevic, S. J., & Palada, I. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.05.011 · Cited by 17
Does endothelial dysfunction correlate with endocrinal abnormalities in patients with polycystic ovary syndrome?
Dube, R. (2016) · Avicenna Journal of Medicine · doi:10.4103/2231-0770.191445 · Cited by 17
Polycystic ovarian syndrome-associated cardiovascular complications: An overview of the association between the biochemical markers and potential strategies for their prevention and elimination
JAVN, S., Thomas, S., Ramachandran, S., Loganathan, S., Sundari, M., & Mala, K. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.07.004 · Cited by 17

Authors: Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E.
Affiliations: The University of Adelaide (AU)
Centre Hospitalier Universitaire de Lille (FR)
Pennsylvania State University (US)
Corresponding author: Hickey, Theresa E
ORCID: Norman, Robert J
Dewailly, Didier
Legro, Richard S
Hickey, Theresa E
Venue: The Lancet
Publisher: Elsevier BV
Published: 2007-08
Volume: 370
Issue: 9588
Pages: 685-697
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(07)61345-2
OpenAlex: W2499178053
Cited by: 1,360
References: 181
Citations by year: 2026: 43 · 2025: 61 · 2024: 100 · 2023: 100 · 2022: 101 · 2021: 105 · 2020: 94 · 2019: 86 · 2018: 86 · 2017: 74 · 2016: 78 · 2015: 70 · 2014: 62 · 2013: 52 · 2012: 60
FWCI: 6.99
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
Keywords: polycystic ovary syndrome, hyperandrogenism, insulin resistance, menstrual disorders, infertility, hirsutism, acne, obesity, metabolic syndrome, type 2 diabetes, cardiovascular disease, diagnostic criteria, chronic anovulation, polycystic ovary, genetic susceptibility, lifestyle factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Polycystic ovary syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks